Praio

What Praio does

Praio is a privately held biotechnology company developing artificial protocells for next-generation biocatalysis. Its core technology combines polymeric components with enzymes to form tunable microenvironments that recreate the supportive local conditions in which enzymes naturally function, improving catalytic rate, yield, stability, organic solvent compatibility, and reusability without requiring enzyme redesign. The platform architecture is delivered through a tiered product workflow: an Environment Screening Panel for broad initial screening against existing enzymes and assays, Granular Optimization Screens for refining hits across formulation, loading, and solvent variables, and a Process-Deployable Protocell Catalyst for manufacturing integration with recovery and reuse via centrifugation or filtration.

Praio targets industrial biotech and biocatalysis users, including pharmaceutical, fine chemical, and biotech manufacturing organizations seeking to address enzyme performance gaps under demanding industrial reaction conditions. The company is supported by a network of research institutions and accelerators, including UCLA, Berkeley Lab, Cyclotron Road, U.S. Department of Energy, Activate, BioPACIFIC MIP, Ray of Hope Accelerator, Biomimicry Institute, Safar Partners, and NSF I-Corps. The founding team is led by Advait Holkar (Founder and CEO) with Samanvaya Srivastava serving as Scientific Advisor.

Praio operates an inside sales motion centered on web-based lead capture: customers submit sample panel requests through structured forms, and Praio follows up to coordinate delivery, optimization, and deployment. Pricing is quote-based and not publicly disclosed. No revenue, headcount, or funding round data has been disclosed, indicating an early commercial stage with the primary revenue mechanic being direct sales of screening panels progressing to longer-term process-deployable catalyst engagements.

Name

Praio

Legal name

Praio

Website

https://praio.co

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Praio is a private biotechnology company developing artificial protocells—tunable microenvironments combining polymeric components with enzymes—to improve biocatalysis performance for pharmaceutical, fine chemical, and biotech manufacturing customers without requiring enzyme redesign.

Ownership category

akta.pro rank

Product category

Industrial Biotechnology / Biocatalysis Materials

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)

SIC

Industrial Organic Chemicals (2860), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Engineered Microbial Therapeutics (synthetic biology, gene circuits) (HLAAAFAD)

Keywords

• Artificial protocells
• Enzyme biocatalysis
• Industrial biotechnology
• Enzyme environment engineering
• Biocatalysis screening

Headquarters

HQ city

Berkeley

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Environment Screening Panel Sales: Praio generates revenue through direct sales of its Environment Screening Panel product. Customers request sample panels through the website, and Praio follows up to coordinate delivery. The workflow progresses from screening panel to granular optimization to process-deployable protocell catalyst format for recovery and reuse.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Praio develops and sells artificial protocells — tunable microenvironments that combine polymeric components with enzymes to recreate supportive local conditions for biocatalysis. The company sells an Environment Screening Panel of these microenvironments to industrial biotech, pharmaceutical, and fine chemical users who want to improve enzyme reaction rate, yield, stability, solvent compatibility, and reuse without redesigning the enzyme itself.

Product overview

Praio offers a platform of artificial protocell products for biocatalysis applications. The core product is the Artificial Protocell technology - tunable microenvironments combining polymeric components with enzymes. The product portfolio includes the Environment Screening Panel (for initial screening of microenvironments against existing enzymes), Granular Optimization Screens (for refining hits), and Process-Deployable Protocell Catalyst (the final formulation for industrial use). Users start with the Environment Screening Panel, progress to optimization screens, and ultimately deploy the process-ready protocell catalyst.

Differentiator

Problem solved

Functional benefit

Brands

• Environment Screening Panel: A screening product for testing engineered microenvironments against existing enzyme and assay workflows
• Artificial Protocells

Products and services

• Artificial Protocells Tunable microenvironments combining polymeric components with enzymes to form artificial protocells that support biocatalysis, improving rate, yield, stability, and solvent compatibility without enzyme redesign. Targeted at industrial biotech and biocatalysis users running enzyme reactions for chemical synthesis.
• Environment Screening Panel A curated set of microenvironments for screening against existing enzymes and assays, allowing users to identify optimal protocell formulations for their specific reactions. Customers request sample panels via Praio's website and the company coordinates delivery.
• Granular Optimization Screens Expanded screening services around identified hits to tune formulation, loading, solvent compatibility, and stability for optimal performance. Represents the second stage of Praio's customer workflow after initial Environment Screening Panel screening.
• Process-Deployable Protocell Catalyst Final catalyst format that translates the best formulation into a deployable format for enzyme recovery, reuse, and integration into manufacturing processes. The third stage of Praio's customer workflow following screening and optimization.

Quantifiable outcome

• Multifold rate enhancement across substrate concentrations and mixed-solvent conditions including 8% isobutanol
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Carbios: Carbios develops enzyme-based processes for plastic recycling and biodegradation, applying industrial biocatalysis to chemical manufacturing. Praio's protocell platform addresses the same enzyme performance challenges Carbios faces in scaling biocatalytic processes.
• Bota Bio: Bota Bio is a synthetic biology company developing industrial bioprocesses for chemicals and materials using engineered microorganisms. Like Praio, Bota Bio applies synthetic biology to industrial biocatalysis, though focused on organism engineering rather than enzyme environment engineering.
• Codexis: Codexis engineers enzymes for pharmaceutical and industrial applications, including biocatalysis for fine chemicals. Praio's protocell platform competes for the same industrial enzyme optimization use cases but takes an environment-engineering approach rather than protein engineering.

Others

• Culture Biosciences: Culture Biosciences provides bioprocess development and fermentation services to industrial biotech companies. It is an enabling service provider that could support Praio's scale-up activities or compete for the same customer R&D budgets.

Broad incumbents

• Novonesis: Novonesis (formed from the Novozymes-Chr. Hansen merger) is a global leader in industrial enzymes and microbial products serving food, agriculture, and industrial biotech. It serves as a broad incumbent whose enzyme engineering and supply capabilities could envelop Praio's niche if the protocell approach proves valuable.
• Amyris: Amyris pioneered industrial-scale synthetic biology for specialty chemicals and ingredients using engineered yeast. Despite its restructuring, Amyris represents the broader industrial biotech incumbents applying engineered biology to chemical manufacturing - the same opportunity Praio targets.
• Ginkgo Bioworks: Ginkgo Bioworks operates a synthetic biology platform for cell engineering across industrial biotech applications. As a broad platform player, Ginkgo competes for industrial biotech partnerships and could expand into enzyme environment engineering if the approach proves scalable.
• LanzaTech: LanzaTech commercializes gas fermentation using engineered acetogens to convert waste gases into chemicals and fuels. It represents industrial biotech incumbents applying engineered biological systems to chemical manufacturing, addressing similar end-market opportunities as Praio.

Emerging players

• Cradle: Cradle applies AI/ML to protein design and engineering for industrial biotech applications. As an emerging player in the enzyme optimization space, Cradle represents adjacent approaches to industrial enzyme performance - the same problem Praio's protocell platform addresses.
• DMC Biotechnologies: DMC Biotechnologies develops microbial bioprocesses for sustainable chemical manufacturing, applying synthetic biology to industrial fermentation. As an emerging player, it competes for the same early-stage industrial biotech partnerships and demonstrates the active competitive landscape.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/praiotech

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Praio